A paper in PNAS this week reporting that a signature of microRNA (miRNA) gene expression correlates with diagnosis and prognosis of B-cell chronic lymphocytic leukemias (CLLs) has drawn skepticism ...

Slit-Robo GTPase-activating protein 3 contains a Rho GAP domain that regulates the activities of Rho family GTPases and affects actin polymerization, which influences dendrite elaboration, neurite ...

Feb. 1, 2011, 8:45 AM UTC / Source: GlobeNewswire COPENHAGEN, Denmark, Feb. 1, 2011 (GLOBE NEWSWIRE) -- Exiqon A/S (Copenhagen:EXQ) today announced the launch of its 2011 global research grant program ...

Analyzing gene expression can provide a roadmap for deciphering the role of specific genes or elaborating critical players in functional metabolic pathways. Companies are pursuing solutions to better ...

The enormous potential of miRNAs is driving new technologies for research, diagnostic, and therapeutic applications. miRNAs, a class of small noncoding RNAs of 19–30 nucleotides in length, regulate ...

We present a microarray technology for researchers carrying out microRNA (miRNA) profiling, who are looking for a more flexible alternative to preprinted arrays. Geniom ® One is a benchtop instrument ...

DUBLIN--(BUSINESS WIRE)--The "Cancer Profiling and Pathways: Technologies and Global Markets" report has been added to ResearchAndMarkets.com's offering. Cancer biomarkers have gained significant ...

We analyzed two genome-wide microRNA (miRNA) expression profiling data sets from tumor tissue samples for in silico discovery (GSE68204) and validation (GSE29298). We prioritized biomarkers in ...

Show More From the Departments of Molecular Virology, Immunology and Medical Genetics and Comprehensive Cancer Center, Ohio State University, Columbus, OH; Departments of Pathology and Surgical and ...

COLUMBUS, Ohio – Scientists mining vast, largely unexplored regions of the human genome have identified a small handful of mini-molecules that play a major role in the development of cancer and ...

Frost & Sullivan has released a new report showing that the U.S. MicroRNA Market earned revenues of over $20.3 million in 2008. The firm estimates this to reach $98.6 million in 2015. The U.S.